These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7545533)

  • 21. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats.
    Ke HZ; Crawford DT; Qi H; Simmons HA; Owen TA; Paralkar VM; Li M; Lu B; Grasser WA; Cameron KO; Lefker BA; DaSilva-Jardine P; Scott DO; Zhang Q; Tian XY; Jee WS; Brown TA; Thompson DD
    J Bone Miner Res; 2006 Apr; 21(4):565-75. PubMed ID: 16598377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen and "exercise" have a synergistic effect in preventing bone loss in the lumbar vertebra and femoral neck of the ovariectomized rat.
    Li CY; Jee WS; Chen JL; Mo A; Setterberg RB; Su M; Tian XY; Ling YF; Yao W
    Calcif Tissue Int; 2003 Jan; 72(1):42-9. PubMed ID: 12370795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of dihydrotestosterone alone and combined with estrogen on bone mineral density, bone growth, and formation rates in ovariectomized rats.
    Coxam V; Bowman BM; Mecham M; Roth CM; Miller MA; Miller SC
    Bone; 1996 Aug; 19(2):107-14. PubMed ID: 8853853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alteration in the mechanical competence and structural properties in the femoral neck and vertebrae of ovariectomized rats.
    Peng Z; Tuukkanen J; Zhang H; Väänänen HK
    J Bone Miner Res; 1999 Apr; 14(4):616-23. PubMed ID: 10234584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of prostaglandin E2 and F2 alpha on the skeleton of osteopenic ovariectomized rats.
    Ma YF; Li XJ; Jee WS; McOsker J; Liang XG; Setterberg R; Chow SY
    Bone; 1995 Dec; 17(6):549-54. PubMed ID: 8835309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia.
    Ke HZ; Shen VW; Qi H; Crawford DT; Wu DD; Liang XG; Chidsey-Frink KL; Pirie CM; Simmons HA; Thompson DD
    Bone; 1998 Sep; 23(3):249-55. PubMed ID: 9737347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity.
    Sato M; Westmore M; Ma YL; Schmidt A; Zeng QQ; Glass EV; Vahle J; Brommage R; Jerome CP; Turner CH
    J Bone Miner Res; 2004 Apr; 19(4):623-9. PubMed ID: 15005850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of growth hormone and low dose estrogen on bone growth and turnover in long bones of hypophysectomized rats.
    Kidder LS; Schmidt IU; Evans GL; Turner RT
    Calcif Tissue Int; 1997 Oct; 61(4):327-35. PubMed ID: 9312204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin E2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats.
    Jee WS; Mori S; Li XJ; Chan S
    Bone; 1990; 11(4):253-66. PubMed ID: 2242291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Odanacatib, effects of 16-month treatment and discontinuation of therapy on bone mass, turnover and strength in the ovariectomized rabbit model of osteopenia.
    Duong LT; Crawford R; Scott K; Winkelmann CT; Wu G; Szczerba P; Gentile MA
    Bone; 2016 Dec; 93():86-96. PubMed ID: 27639811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of pre- and post-surgery treatment with risedronate on trabecular bone loss in ovariectomized rats.
    Iwamoto J; Takeda T; Sato Y; Shen CL; Yeh JK
    Exp Anim; 2006 Oct; 55(5):457-66. PubMed ID: 17090962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive increases in bone mass and bone strength in an ovariectomized rat model of osteoporosis after 26 weeks of treatment with a sclerostin antibody.
    Li X; Niu QT; Warmington KS; Asuncion FJ; Dwyer D; Grisanti M; Han CY; Stolina M; Eschenberg MJ; Kostenuik PJ; Simonet WS; Ominsky MS; Ke HZ
    Endocrinology; 2014 Dec; 155(12):4785-97. PubMed ID: 25259718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of osteopenic changes in cancellous bone induced by ovariectomy and/or immobilization in adult rats.
    Bagi CM; Miller SC
    Anat Rec; 1994 Jul; 239(3):243-54. PubMed ID: 7943756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized rats.
    Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
    Exp Anim; 2006 Jul; 55(4):357-67. PubMed ID: 16880683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the response of pelvic and proximal tibial cancellous bone in rat to ovariectomy with estrogen replacement.
    Hodsman AB; Kiesel M; Fraher LJ; Watson PH; Stitt LW
    Bone; 1998 Sep; 23(3):267-74. PubMed ID: 9737349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcitonin provides complete protection against cancellous bone loss in the femoral neck of ovariectomized rats.
    Shen Y; Li M; Wronski TJ
    Calcif Tissue Int; 1997 May; 60(5):457-61. PubMed ID: 9115164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of the bone-restorative efficacy of anabolic agents in aged ovariectomized rats.
    Iwaniec UT; Moore K; Rivera MF; Myers SE; Vanegas SM; Wronski TJ
    Osteoporos Int; 2007 Mar; 18(3):351-62. PubMed ID: 17120182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clodronate prevents osteopenia and loss of trabecular connectivity in estrogen-deficient rats.
    Kippo K; Hannuniemi R; Isaksson P; Laurén L; Osterman T; Peng Z; Tuukkanen J; Kuurtamo P; Väänänen HK; Sellman R
    J Bone Miner Res; 1998 Feb; 13(2):287-96. PubMed ID: 9495523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats.
    Yao W; Tian XY; Chen J; Setterberg RB; Lundy MW; Chmielzwski P; Froman CA; Jee WS
    J Musculoskelet Neuronal Interact; 2007; 7(2):119-30. PubMed ID: 17627081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.